Colorectal cancer Clinical Trials
Recruiting colorectal cancer studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat colorectal cancer. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting colorectal cancer studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting colorectal cancer trials
Reducing Neoplasia Recurrence After Non-thermal Endoscopic Resection of Large Colorectal Polyps
Increasing CRC Screening in Community Health Centers Through Mobile Messaging Optimization
Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer
Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
CPHARM - CRC Study
IKS04 Regimen in Advanced Solid Tumors That Express CA242
Tucatinib Continuation Study
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
Transanal Irrigation for the Management of Early Low Anterior Resection Syndrome (LARS)
Researching the Effect of Exercise on Cancer
A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.
Preventing Early-Onset Colorectal Cancer in the VA
Evaluation of Versatile Intelligent Staining Technology (VIST) and Spectral Flexible Imaging (SFI) for Detection and Optical Characterization of Colorectal Lesions: A Prospective Randomized Controlled Study
Colorectal Cancer Screening in the Homeless
A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers
Nutritional Supplementation to Improve Colorectal Cancer Surgery
Mind-Body Interventions for the Improvement of Quality of Life, Stress, and Sleep Quality Among Survivors of Breast, Prostate, Endometrial, or Colorectal Cancer
Increasing Breast and Colorectal Cancer Screening in the Community
Improving Colorectal Cancer Screening Uptake Through Education and Stool-Based Testing Outreach
Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status
Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)
Colon Health Champion Program
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
The PharmFIT Study
NOMAD-GI: Molecular-guided Non-operative Management and Organ Preservation Strategy After Precision Therapy in Gastrointestinal Cancers
Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer
Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients
Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors
TCR1188-ABC Cells in KRAS-mutated Cancers
Tovecimig Plus FOLFIRI in Second Line Metastatic Colorectal Cancer
A Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan
A Study of IOV-5001 in Adults With Advanced Solid Tumors
Implementation Of A Telesurgery Program At A Referral Center For Robotic Surgery
Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
Prospective Assessment of Alignment Between Multimodal Artificial Intelligence and Multidisciplinary Team Decisions in Gastrointestinal Oncology
Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients
Triton 1.5 Robotic System for Diagnostic Colonoscopy
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Liver-directed Chemotherapy After Surgery of Liver Metastases of Colorectal Cancer in Patients With High Risk of Recurrence of Their Disease
A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)
A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer
Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers
IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Protective Role of Alpha-Lipoic Acid in Chemotherapy-Induced Mucositis
Guardant Shield Colorectal Cancer Screening
Qigong Exercise for Muscles Strength and Quality of Life in Colorectal Cancer Patients Undergoing Chemotherapy
A One-year Follow-up of Incisional Hernia Formation Between Device Assisted and Manual Laparotomy Closure
Evaluation of XYA02 in Patients With Advanced Solid Tumors
Development and Validation of a Colorectal Cancer Diagnostic Model
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
SL-28 for Advanced Solid Tumours
GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer
New trials in Los Angeles, CA?
Pick a condition and we'll email you once a week when a new study starts recruiting in Los Angeles, CA. Unsubscribe anytime.
Colorectal cancer clinical trials — common questions
Are colorectal cancer clinical trials free to join?
Yes. Participating in a colorectal cancer clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a colorectal cancer clinical trial?
Each colorectal cancer study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a colorectal cancer trial near me?
Use the location controls above. We'll show recruiting colorectal cancer trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many colorectal cancer trials are recruiting right now?
We're currently tracking roughly 238 recruiting colorectal cancer trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.